Inadequate Provision for Electoconvulsive Therapy in the New South Wales Mental Health Act 1983

References

• Leffell M S, Lumsden L O, Steiger W A. An analysis of T-lymphocyte sub-populations in patients with Alzheimer's Disease. Journal of American Geriatric Society 1985; 33(4)4–8
   PubMedGoogle Scholar
• Goodman J W. Immunogenicity and antigenic specificity. Basic and Clinical Immunology Los Altos California: Applelon and Lange, D P Stites, J D Stobo, J V Wells, 1987
   Google Scholar
• Werb Z. Phagocytic Cells: Chemotaxis and Effector Functions of Macrophages and Granulocytes. Basic and Clinical Immunology, D Stites, J D Stobo, J V Wells. Appleton and Lange, Los Altos, California 1987
   Google Scholar
• Stobo J D. Lymphocytes. Basic and Clinical Immunology, D Stites, J D Stobo, J V Wells. Appleton and Lange, Los Altos, California 1987
   Google Scholar
• Kiecolt-Glasser J K, Glaser R. Psychological influences on immunity. Psychosomatics 1986; 27: 621–624
   PubMedGoogle Scholar
• Herberman R B. Natural killer cells. Annual Review of Medicine 1986; 37: 347–352
   PubMed Web of Science ®Google Scholar
• Levitt D., Cooper M D. Lymphocytes-B cells. Basic and Clinical Immunology: Los Altos, D. Stites, J D Stobo, J V Wells. Appleton and Lange, California 1987
   Google Scholar
• Oppenheim J J, Ruscetti F W, Faltynek C R. Interleukins and Interferons. Basic and Clinical Immunology, D P Stites, J D Stobo, J V Wells. Appleton and Lange, Los Altos, California 1987
   Google Scholar
• Roitt I, Brostoff M. J., Male D K. Major Histocompatibility Complex. Slide atlas of immunology Volume I. Gower Medical Publishing Ltd, London 1985
   Google Scholar
• Lloyd R. Mechanisms of Psychoneuroimmunological Response. Impact of Psychoendocrine Systems in Cancer and Immunity, B H Fox, B H Newberry. C S Hogrefe Inc., New York 1984
   Google Scholar
• Calabrese J R, Kling M A, Gold P L. Alterations in immunocompetence during stress, bereavement and depression: Focus on neuroendocrine regulation. American Journal of Psychiatry 1987; 144(9)1123–1134
   PubMed Web of Science ®Google Scholar
• Delisi L E. “Is immune dysfunction associated with sehizophrenia?” A review of the data. Psychopharmacology Bulletin 1984a; 20(3)509–513
   PubMedGoogle Scholar
• Ferguson R, Schmidtke M., Simmons R L. Effects of psychoaelive drugs on in vitro lymphocyte activation. Neurochemical and Immunological Components of Schizophrenia, D. Bergsma, A L Goldstein. Alan R Liss Inc, New York 1978; Vol 14
   Google Scholar
• Lovett C, Ulrich L. J, Simms T. BG, . Effects of chlorpromazime on antibody production in vitro. Neurochemical and Immunological Components of Schizophrenia, D Bergsma, A L Goldstein, et al. Alan R Liss Inc., New York 1978; Vol 14
   Google Scholar
• Curry S H. Metabolism and kinetics of chlorpromazine in relation to effect. Antipsychotic drugs: Pharmacodynamics and pharmacokinetics, G. Sedvall, B. Uvnes, Y Zotterman. Pergamon Press, Oxford 1976
   Google Scholar
• Hirata-Hibi M, Higashi S., Tachibana T, et al. Stimulated lymphocytes in schizophrenia. Archives of General Psychiatry 1982; 39: 82–87
   PubMedGoogle Scholar
• DeLisi L E, Wyatt R J. Abnormal immune regulation in schizophrenicpatients. Psychopharmacology Bulletin 1982; 18: 158–163
   PubMedGoogle Scholar
• DeLisi L E, Ortaldo J R, Maluish A E, et al. Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients. Journal of Neural Transmission 1983; 58: 99–106
   PubMedGoogle Scholar
• Morozov P V. Research on the Viral Hypothesis of Mental Disorders. Advances in Biological Psychiatry, P Morozov. Karger, Basel 1983; Vol 12
   Google Scholar
• Hare E H. Epidemiological evidence for a viral factor in the aetiology of the functional psychoses. Advances in Biological Psychiatry, P Morozov. Karger, Basel 1983; Vol 12
   Google Scholar
• Crow T J, Taylor G R, Tyrrell D A. Two syndromes in schizophrenia and the viral hypothesis. Handbook of Studies on Schizophrenia Part I, G D Burrows, T R Norman, V P Rubenstein. Elsevier Science Publishers, NY 1986
   Google Scholar
• Meltzer H Y. Biological studies in schizophrenia. Schizophrenia Bulletin 1987; 13(1)77–111
   PubMedGoogle Scholar
• Solomon G, Allansmith F., McClellan M., et al. Immunoglobulins in psychiatric patients. Archives of General Psychiatry 1969; 20: 272–277
   PubMed Web of Science ®Google Scholar
• Gowdy J. Immunoglobulin levels in psychiatric patients. Psychosomatics 1980; 21(9)751–756
   PubMedGoogle Scholar
• DeLisi L E, King A, Targum C. S. Serum immunoglobulin concentrations in patients admitted to an acute psychiatric inpatient service. British Journal of Psychiatry 1984b; 145: 661–666
   PubMedGoogle Scholar
• Pulkkinen E, Soininvaara O. Immunoglobulins in schizophrenics and prediction of need for hospital care. Acta Psychiatrica Scandinavica 1985; 72: 133–138
   PubMedGoogle Scholar
• Legros S, Mendlewicz J., Wybran J. Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. European Archives of Psychiatry and Neurological Sciences 1985; 235: 9–11
   PubMedGoogle Scholar
• Chu A B, Sever J L, Madden D L, et al. Oligoclonal 1gG bands in cerebrospinal fluid in various neurological diseases. Annual Neurology 1983; 13: 434–439
   PubMed Web of Science ®Google Scholar
• Ahokas A., Koskiniemi M L, Vaheri A, et al. Altered white cell count, protein concentration and oligoclonal 1gG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders. Neuropsychobiology 1985; 14: 1–4
   PubMedGoogle Scholar
• Roos R P, Davis K, Meltzer H Y. Immunoglobulin studies in patients with psychiatric diseases. Archives of General Psychiatry 1985; 42: 124–128
   PubMedGoogle Scholar
• DeLisi L E. Immunological disturbances in psychiatric patients. Letter; Archives of General Psychiatry 1986; 43: 189–190
   PubMedGoogle Scholar
• Torrey E F, Yolken R H, Albrecht P. Cylomegalovirus as a possible actiological agent in schizophrenia. Advances in Biological Psychiatry, P Morozov. Karger, Basle 1983; Vol 12
   Google Scholar
• Albrecht P, Torrey E, Boone F. E. Raised cytomegalovirus antibody level in cerebrospinal fluid of schizophrenic patients. Lancet 1980; ii: 769–772
   Google Scholar
• Shrikhande S., Hirsch S, Coleman R. J C, et al. Cytomegalovirus and schizophrenia. A test of the viral hypothesis. British Journal of Psychiatry 1985; 146: 503–506
   PubMedGoogle Scholar
• Rimon R, Ahokas A, Palo J. Serum and cerebrospinal fluid antibodies to cytomegalovirus in schizophrenia. Acta Psychiatrica Scandinavica 1986; 73: 642–644
   PubMed Web of Science ®Google Scholar
• King D J, Cooper S J, Earle J A, et al. A survey of serum antibodies to eight common viruses in psychiatric patients. British Journal of Psychiatry 1985a; 147: 137–144
   PubMedGoogle Scholar
• King D J, Cooper S J, Earle J A, et al. Serum and CSF antibody titres to seven common viruses in schizophrenic patients. British Journal of Psychiatry 1985b; 147: 145–149
   PubMed Web of Science ®Google Scholar
• Gottlieb-Stematsky T, Zonis J, Arlazoff A, et al. Antibodies to Epstein-Barr virus, herpes simplex type I, cytomegalovirus and measles virus in psychiatric patients. Archives of Virology 1981; 67: 333–339
   PubMedGoogle Scholar
• Libikova H. Schizophrenia and Viruses: Principles of Aetiologic Studies. Advances in Biological Psychiatry, P Morozov. Karger, Basel 1983; Vol 12
   Google Scholar
• Robert-Guroff M, Torrey E F, Brown M. Retroviruses and schizophrenia. Letter to the editor. British Journal of Psychiatry 1985; 146: 326
   PubMedGoogle Scholar
• Preble O T, Torrey E F. Serum Interferon in patients with psychosis. American Journal of Psychiatry 1985; 142: 1184–1186
   PubMedGoogle Scholar
• Schindler L, Leroux M, Beck, et al. Studies of cellular immunity, serum interferon titres, and natural killer cell activity in schizophrenic patients. Acta Psychiatrica Scandinavica 1986; 73: 651–657
   PubMedGoogle Scholar
• Roy A, Pickar D, Ninan P. A search for interferon in the CSF of chronic schizophrenic patients Letter. American Journal of Psychiatry 1985; 142: 269
   PubMedGoogle Scholar
• Rimon R H, Halonen P, Lebon P, . Antibrain antibodies and interferon in the serum and cerebrospinal fluid of patients with schizophrenia. Research on the viral hypothesis of mental disorders, P Morozov, et al. Karger, Basel 1983
   Google Scholar
• Moises H W, Schindler L, Leroux M, et al. Decreased production of interferon alpha and interteron gamma in leucocyte cultures of schizophrenic patients. Acta Psychiatrica Scandinavica 1985; 72: 45–50
   PubMedGoogle Scholar
• Abi-Hanna D, Wakefield D. Increased serum neopterin levels in patients with acute anterior uveitis. Current Eye Research 1988, in press
   PubMedGoogle Scholar
• Fessel W J. Autoimmunity and mental illness: Preliminary report. Archives of General Psychiatry 1962; 6: 320–323
   PubMedGoogle Scholar
• Theofilopoulos A N. Autoimmunity. Basic and Clinical Immunology, D P Stites, J D Stobo, J V Wells. Appleton and Lange, Los Altos, California 1987
   Google Scholar
• Owen F, Cross A J, Crow T J, et al. Increased dopamine-receptor sensitivity in schizophrenia. Lancet 1978; ii: 223–225
   Google Scholar
• Knight J G. Is schizophrenia an autoimmune disease? A review. Methods and Findings Clinical Pharmacology 1984; 6(7)395–403
   PubMedGoogle Scholar
• Knight J G. Dopamine-receptor-stimulating autoantibodies: A possible cause of schizophrenia. The Lancet 1982; 1073–1075, Nov
   PubMedGoogle Scholar
• Roberts D F, Kinnell H G. Editorial: Immunogenetics and schizophrenia. Psychological Medicine 1981; 11: 441–442
   PubMedGoogle Scholar
• Heath R G, Martens S, Leach B E, et al. Effects of behaviour in humans with the administration of taraxein. American Journal of Psychiatry 1957; 114: 14
   PubMed Web of Science ®Google Scholar
• Bergen J R, Grinspoon L, Pyle H M, et al. Immunologic studies in schizophrenic and control subjects. Biological Psychiatry 1980; 15: 369–379
   PubMedGoogle Scholar
• DeLisi L E, Weber R J, Pert C B. Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus. Biological Psychiatry 1985; 20: 94–119
   PubMedGoogle Scholar
• Kolyaskina G I. Blood lymphocytes in schizophrenia-Immunological and virological aspects. Advances in Biological Psychiatry Vol 12, P Morozov. Karger, Basel 1983
   Google Scholar
• Gottesman I I, McGuffin P, Farmer A E. Clinical genetics as clues to the “real” genetics of schizophrenia. Schizophrenia Bulletin 1987; 13(1)23–47
   PubMedGoogle Scholar
• Schindler B A. Stress, affective disorders and immune function. Medical Clinics of North America 1985; 69(3)585–597
   PubMed Web of Science ®Google Scholar
• Kronfol Z, Silva J, Jr., Greden J, et al. Impaired lymphocyte function in depressive illness. Life Sciences 1983; 33(3)241–247
   PubMedGoogle Scholar
• Schleifer S J, Keller S E, Meyerson A T, et al. Lymphocyte function in major depressive disorder. Archives of General Psychiatry 1984; 41: 484–486
   PubMed Web of Science ®Google Scholar
• Schleifer S J, Keller S E, Siris S G, et al. Depression and immunity: Lymphocyte functions in ambulatory depressed patients, hospitalised schizophrenic patients and patients hospitalised for herniorrhaphy. Archives of General Psychiatry 1985; 42: 129–133
   PubMed Web of Science ®Google Scholar
• Calabrese J R, Skwerer R C, Barna B, et al. Depression, immunocompetence and prostaglandins of the E series. Psychiatry Research 1986; 17: 41–47
   PubMed Web of Science ®Google Scholar
• Linn M N, Linn B S, Jensen J. Stressful events, dysphoric mood and immune responsiveness. Psychological Reports 1984; 54: 219–2265
   PubMed Web of Science ®Google Scholar
• Albrecht J J, Heldemar J H, Schlesser M A, et al. A controlled study of cellular immune function in affective disorder before and during somatic therapy. Psychiatry Research 1985; 15: 185–193
   PubMedGoogle Scholar
• Sengar D P, Waters B G, Dunne J V, et al. Lymphocyte subpopulations and mitogenic responses of lymphocytes in manic-depressive disorders. Biological Psychiatry 1982; 17(9)1017–1022
   PubMedGoogle Scholar
• Lycke E, Roos B E. Influences of changes in brain monoamine metabolism on behaviour of herpes simplex-infected mice. Journal of Neurology 1974; 22: 277–289
   Google Scholar
• Rimon R, Halonen P, Anttinen E, et al. Complement fixing antibody to herpes simplex virus in patients with psychotic depression. Diseases of the Nervous System Dec, 1971; 822–824
   PubMedGoogle Scholar
• Lycke E, Norby E, Roos B E. A serological study of mentally ill patients with particular reference to the prevalence of herpes virus infections. British Journal of Psychiatry 1974; 124: 273–279
   PubMed Web of Science ®Google Scholar
• Cappel R, Gregiore F, Thirley L, et al. Antibody and cell mediated immunity to herpes simplex virus in psychotic depression. Journal of Clinical Psychiatry 1978; 39(3)266–268
   PubMedGoogle Scholar
• Editorial. The Lancet June 27, 1987; 1467–1468
   Google Scholar
• Wakefield D, Lloyd A. Pathophysiology of Myalgic Encephalitis. Letter; The Lancet Oct 17, 1987; 918–919
   Google Scholar
• Tecoma E S, Huey L Y. Psychic distress and the immune system. Life Sciences 1985; 36(19)1799–1812
   PubMedGoogle Scholar
• Banrop R W, Lazarus L, Luckhurst E, et al. Depressed lymphocyte function after bereavement. Lancet 1977; i: 834–836
   Google Scholar
• Parkes C M. Bereavement: Studies of grief in adult life. International University Press, New York 1972
   Google Scholar
• Schleifer S J, Keller S E, Camerino M, et al. Suppression of lymphocyte stimulation following bereavement. Journal of the American Medical Association 1983; 250: 374–377
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J K, Fisher L D, Ogrocki P, et al. Marital quality, marital disruption and immune finction. Psychosomatic Medicine 1987; 49(1)13–34
   PubMed Web of Science ®Google Scholar
• Arnetz B B, Wasserman T, Petrini B, et al. Immune function in unemployed women. Psychosomatic Medicine 1987; 49: 3–12
   PubMed Web of Science ®Google Scholar
• Linn B S, Linn M N, Jensen J. Degree of depression and immune responsiveness. Psychosomatic Medicine 1982; 44: 128–129
   Google Scholar
• Irwin M, Daniels M, Bloom E T, et al. Life events, depressive symptoms and immune function. American Journal of Psychiatry 1987; 144(4)437–441
   PubMed Web of Science ®Google Scholar
• Lazarus R S, Averill J R, Opton E M, Jr. The psychology of coping: Issues of research and assessment. Coping and Adaptation, G V Coelho, D A Hamburg, J E Adams. Basic Books, New York 1974
   Google Scholar
• Levine S, Weinberg T, Ursin H. Definition of the coping process and statement of the problem. Psychobiology of Stress, H Ursin, E Baade, S Levine, Lillfind 1978
   Google Scholar
• Dorian B, Garfinkel P, Brown G. Aberrations in lymphocyte sub-populations and function during psychological stress. Clinical and Experimental Immunology 1982; 50(i)132–138
   PubMedGoogle Scholar
• Locke S E, Kraus L, Leserman, et al. Life change stress, psychiatric symptoms and natural killer cell activity. Psychosomatic Medicine 1984; 46: 441–453
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J K, Garner L, Speicher C, et al. Psychosocial modifiers of immunocompetence in medical students. Psychosomatic Medicine 1984a; 46(1)7–14
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J K, Ricker D, George J, et al. Urinary cortisol levels, cellular immuno-competency and loneliness in psychiatric inpatients. Psychosomatic Medicine 1984b; 46(1)15–23
   PubMed Web of Science ®Google Scholar
• Heisal J S, Locke S E, Kraus L J, Williams R M. Natural killer cell activity and MMPI. Scores of a cohort of college and students. American Journal of Psychiatry 1986; 143(11)1382–1386
   PubMedGoogle Scholar
• Amman A J. Immunodeficiency Disease. Basic and Clinical Immunology, Appleton and Lange, D Stites, J D Stobo, J V Wells, Los Altos, California 1987
   Google Scholar
• Pettingale K W. Towards a psychobiological model of cancer: Biological considerations. Social Science Medicine 1985; 20: 779–787
   PubMed Web of Science ®Google Scholar
• Greenberg P D. Tumour Immunology. Basic and Clinical Immunology: Los Altos California, D Stites, J D Stobo, J V Wells. Appleton and Lange. 1987
   Google Scholar
• Hall N R, Goldstein A L. Thinking well-The chemical links between emotions and health. The Sciences March/April, 1986; 34–40
   Google Scholar
• Sklar L, Anisman H. Social stress influences tumour growth. Psychosomatic Medicine 1980; 42: 347–365
   PubMed Web of Science ®Google Scholar
• Laudenslager M, Ryan S, Drugan R, et al. Coping and immunosup-pression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science 1983; 221: 568–570
   PubMed Web of Science ®Google Scholar
• Greenberg A H, Dyck D G, Sandler L S. Opponent processes, neurohormones and natural resistance. Impact of Psychoendocrine Systems in Cancer and Immunity, B H Fox, D Newburg. C J Hogofe Inc., New York 1984
   Google Scholar
• Levy S M, VanDyke L., Temoshok L, Zegram L. Emotions in Health and Illness: Applications to clinical practice. Grune and Stratton, New York 1983
   Google Scholar
• Fox B H. Current theory of psychogenic effects on cancer incidence and prognosis. Journal of Psychosocial Oncology 1983; 1: 17–31
   Google Scholar
• Greer S, Morris T, Pettingale K W. Psychological response to breast cancer: Effect on outcome. The Lancet Oct 1979; 13: 785–787
   Google Scholar
• Pettingale K, Morris T, Greer S, et al. Mental altitudes to cancer: An additional prognostic factor letter. Lancet March, 1984; 756
   Google Scholar
• Greer S, Morris T. Psychological attributes of women who develop breast cancer: A controlled study. Journal of Psychosomatic Research 1975; 19: 147–53
   PubMed Web of Science ®Google Scholar
• Kissen D M. Personality characteristics in males conducive to lung cancer patients. British Journal of Medical Psychology 1963; 36: 27–36
   PubMed Web of Science ®Google Scholar
• Le Shan N. Psychological states as factors in the development of malignant disease: A critical review. Journal of the National Cancer Institute 1959; 22: 1–18
   PubMedGoogle Scholar
• Bahnson C B. Stress and cancer: The state of the art. Psychosomatics 1980; 21: 975–981, Part 1
   PubMed Web of Science ®Google Scholar
• Morris T. A “type C” for cancer. Low trait anxiety in the pathogenesis of breast cancer. Cancer Detection and Prevention 1980; 3
   Google Scholar
• Temoshok L, Heller B W, Sagebiel R W, et al. The relationship of psychosocial factors to prognostic indicators in cutancous malignant melanoma. Journal of Psychosomatic Research 1985; 29: 139–153
   PubMed Web of Science ®Google Scholar
• Kneier A W, Temoshock L. Depressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patients. Journal of Psychosomatic Research 1984; 28: 145–155
   PubMed Web of Science ®Google Scholar
• Derogatis L R, Abeloff M D, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. Journal of American Medical Association 1979; 242: 1504–1508
   PubMed Web of Science ®Google Scholar
• Rogentine G R, Vankammen D P, Fox B H, et al. Psychological factors in the prognosis of malignant melanoma; A prospective study. Psychosomatic Medicine 1979; 41: 647–655
   PubMed Web of Science ®Google Scholar
• Levy S M, Herberman R B, Maluish A M. Prognostic risk assessment in primary breast cancer by behavioural and immunological parameters. Health Psychology 1985; 5: 99–113
   Google Scholar
• Cassileth B R, Lusk E J, Miller D S. Psychosocial correlates of survival in advanced malignant disease?. New England Journal of Medicine 1985; 312: 1551–1555
   PubMed Web of Science ®Google Scholar
• Simonton O C, Matthews-Simonton S, Sparks T F. Psychological intervention in the treatment of cancer. Psychosomatics March, 1980; 21(3)226–233
   PubMedGoogle Scholar
• Mearcs A. Psychological mechanisms in the regression of cancer. The Medical Journal of Australia June 11, 1983; 583–584
   PubMedGoogle Scholar
• Hall H R. Hypnosis and the immune system A review of implications for cancer and the psychology of healing. American Journal of Clinical Hypnosis 1983; 25: 2–3
   Google Scholar
• Newton B W. The use of hypnosis in the treatment of cancer patients. American Journal of Clinical Hypnosis 1983; 25: 2–3
   Google Scholar